A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a Phase 2 clinical trial....
Girls with mental illness or neurodevelopmental conditions are less likely than their peers to be vaccinated with the HPV vaccine that protects against future cervical cancer. ...
The NHS aims to set out plans to improve access to HPV vaccination appointments and maximise cervical screening uptake
The interval between smear tests can safely be extended, experts say
